Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor

No abstract is available for this paper.

• Publication year

  2011

• Venue

  ChemBioChem

• Publication date

  2011-11-04

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/cbic.201100469PMID 21956837PMCID PMC3410710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stabilization of virus-like particles with poly(2-oxazoline)s.

  2011cited by this paper
• Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions.

  2011cited by this paper
• Antitumor activity of NRC-AN-019 in a pre-clinical breast cancer model.

  2011cited by this paper
• Rapid and accurate ranking of binding affinities of epidermal growth factor receptor sequences with selected lung cancer drugs

  2011cited by this paper
• EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence.

  2011cited by this paper
• Clinical relevance of epidermal growth factor receptor (EGFR) alterations in human pancreatic tumors.

  2011cited by this paper
• Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles.

  2011cited by this paper
• Cell selective targeting of a simian virus 40 virus-like particle conjugated to epidermal growth factor.

  2011cited by this paper
• Anti-EGFR monoclonal antibody in cancer treatment: in vitro and in vivo evidence

  2011cited by this paper
• RNA-directed packaging of enzymes within virus-like particles.

  2010cited by this paper
• Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells.

  2010cited by this paper
• Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes.

  2010cited by this paper
• Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors.

  2010cited by this paper
• Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

  2010cited by this paper
• Selection for thermostability can lead to the emergence of mutational robustness in an RNA virus

  2010cited by this paper
• Impact of epidermal growth factor tethering strategy on cellular response.

  2010cited by this paper
• Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel

  2010cited by this paper
• Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

  2010cited by this paper
• Multivalent Display and Receptor‐Mediated Endocytosis of Transferrin on Virus‐Like Particles

  2010cited by this paper
• Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates.

  2010cited by this paper
• Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

  2010cited by this paper
• Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.

  2010cited by this paper
• Heparin Antagonism by Polyvalent Display of Cationic Motifs on Virus‐Like Particles

  2009cited by this paper
• Targeting vault nanoparticles to specific cell surface receptors.

  2009cited by this paper
• Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL).

  2009cited by this paper
• Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation.

  2009cited by this paper
• Assembly of hybrid bacteriophage Qbeta virus-like particles.

  2009cited by this paper
• Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.

  2009cited by this paper
• Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.

  2009cited by this paper
• Knocking down barriers: advances in siRNA delivery

  2009cited by this paper
• Integrated Multifunctional Nanosystems for Medical Diagnosis and Treatment

  2009cited by this paper
• Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.

  2008cited by this paper
• Specific protein delivery to target cells by antibody-displaying bionanocapsules.

  2008cited by this paper
• Immobilization of bacteriophage Qbeta on metal-derivatized surfaces via polyvalent display of hexahistidine tags.

  2008cited by this paper
• Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.

  2008cited by this paper
• Expression of Recombinant Human Epidermal Growth Factor in Escherichia coli and Characterization of its Biological Activity

  2008cited by this paper
• Folate-mediated Cell Uptake of Shell-crosslinked Spheres and Cylinders.

  2008cited by this paper
• Nat. Rev. Drug Disc.

  2007cited by this paper
• A Viral Nanoparticle with Dual Function as an Anthrax Antitoxin and Vaccine

  2007cited by this paper
• GeneDesign: rapid, automated design of multikilobase synthetic genes.

  2006cited by this paper
• Engineering of vault nanocapsules with enzymatic and fluorescent properties.

  2005cited by this paper
• Engineering thermal stability in RNA phage capsids via disulphide bonds.

  2005cited by this paper
• Folate receptor-mediated drug targeting: from therapeutics to diagnostics.

  2005cited by this paper
• Enhanced gene delivery by avidin-displaying baculovirus.

  2004cited by this paper
• Improved Display of Synthetic IgG-Binding Domains on the Baculovirus Surface

  2004cited by this paper
• Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents.

  2002cited by this paper
• Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Epidermal growth factor induces cell cycle arrest and apoptosis of squamous carcinoma cells through reduction of cell adhesion

  2000cited by this paper
• Alexa Dyes, a Series of New Fluorescent Dyes that Yield Exceptionally Bright, Photostable Conjugates

  1999cited by this paper
• Mosaic Qbeta coats as a new presentation model.

  1998cited by this paper
• Mosaic Qβ coats as a new presentation model

  1998cited by this paper
• RNA phage Q beta coat protein as a carrier for foreign epitopes.

  1996cited by this paper
• Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.

  1996cited by this paper
• Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors.

  1996cited by this paper
• RNA Phage Qβ Coat Protein as a Carrier for Foreign Epitopes

  1996cited by this paper
• The crystal structure of bacteriophage Qβ at 3.5 å resolution

  1996cited by this paper
• The crystal structure of bacteriophage Q beta at 3.5 A resolution.

  1996cited by this paper
• Multiple autophosphorylation sites of the epidermal growth factor receptor are essential for receptor kinase activity and internalization. Contrasting significance of tyrosine 992 in the native and truncated receptors.

  1992cited by this paper
• Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines.

  1991cited by this paper
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

  1984cited by this paper
• Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture

  1982cited by this paper
• Identification of the genetic locus for the structural gene and a new regulatory gene for the synthesis of repressible alkaline phosphatase in Saccharomyces cerevisiae

  1982cited by this paper
• Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells

  1981cited by this paper

• Development of a pod pepper vein yellows virus-based expression vector for the production of heterologous protein or virus like particles in Nicotiana benthamiana

  2025cites this paper
• Modular Virus-Like Particles: Building Nanoscale Platforms for Multiple Applications

  2025cites this paper
• Engineering Escherichia coli-Derived Nanoparticles for Vaccine Development

  2024cites this paper
• Stable Cu (I) Complexes for Intracellular Cu-Catalyzed Azide Alkyne Cycloaddition.

  2024cites this paper
• Tailored Viral-like Particles as Drivers of Medical Breakthroughs

  2024cites this paper
• Virus-like particle-based nanocarriers as an emerging platform for drug delivery

  2023cites this paper
• Viruses as biomaterials

  2023cites this paper
• Enhanced Nanobubble Formation: Gold Nanoparticle Conjugation to Qβ Virus-like Particles.

  2023cites this paper
• Development of a Modular NTA:His Tag Viral Vaccine for Co-delivery of Antigen and Adjuvant.

  2023cites this paper
• MS2 Virus-like Particles as a Versatile Peptide Presentation Platform: Insights into the Deterministic Abilities for Accommodating Heterologous Peptide Lengths

  2023cites this paper
• Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis

  2023cites this paper
• Highly modular hepatitis B virus-like nanocarriers for therapeutic protein encapsulation and targeted delivery to triple negative breast cancer cells.

  2023cites this paper
• Engineered protein nanodrug as an emerging therapeutic tool

  2022cites this paper
• Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines

  2022cites this paper
• Virus-like particle – mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection

  2022cites this paper
• Rip it, stitch it, click it: A Chemist's guide to VLP manipulation.

  2022cites this paper
• How promising are HIV-1-based virus-like particles for medical applications

  2022cites this paper
• Protein‐Based Encapsulation Strategies: Toward Micro‐ and Nanoscale Carriers with Increased Functionality

  2022cites this paper
• Virus-inspired Strategies for Cancer Therapy.

  2021cites this paper
• Recombinant turnip yellow mosaic virus coat protein as a potential nanocarrier

  2021cites this paper
• Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells

  2021cites this paper
• Single-Point Mutations in Qβ Virus-like Particles Change Binding to Cells.

  2021cites this paper
• Recent progress in targeted delivery vectors based on biomimetic nanoparticles

  2021cites this paper
• Plant viral nanoparticles for packaging and in vivo delivery of bioactive cargos.

  2020cites this paper
• Modification of Proteins Using Olefin Metathesis.

  2020cites this paper
• Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines

  2020cites this paper
• The Role of Virus-Like Particles in Medical Biotechnology.

  2020cites this paper
• Supramolecular Encapsulation of Small-Ultra Red Fluorescent Proteins in Virus-Like Nanoparticles for Non-Invasive In Vivo Imaging Agents.

  2020cites this paper
• Virus like particles: fundamental concepts, biological interactions, and clinical applications

  2020cites this paper
• A Nonaggregating Heptamethine Cyanine for Building Brighter Labeled Biomolecules

  2019cites this paper
• Nanoparticles applied to cancer immunoregulation.

  2019cites this paper
• Using FRET to measure the time it takes for a cell to destroy a virus.

  2019cites this paper
• Purification, profiling and bioengineering of extracellular vesicles

  2019cites this paper
• Engineering the PP7 Virus Capsid as a Peptide Display Platform.

  2019cites this paper
• Biomolecular Assemblies: Moving from Observation to Predictive Design.

  2018cites this paper
• Protein cage assembly across multiple length scales.

  2018cites this paper
• Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.

  2018cites this paper
• In Vitro Assembly of Virus-Derived Designer Shells Around Inorganic Nanoparticles.

  2018cites this paper
• Polyvalent Hybrid Virus-Like Nanoparticles with Displayed Heparin Antagonist Peptides.

  2018cites this paper
• Decoration of virus-like particles with an enzymatic activity of biomedical interest.

  2018cites this paper
• Bioengineering Strategies for Protein-Based Nanoparticles

  2018cites this paper
• Multifunctional Enzyme Packaging and Catalysis in the Qβ Protein Nanoparticle.

  2018cites this paper
• Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles.

  2018cites this paper
• Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting

  2018cites this paper
• Immunological Properties of Protein-Polymer Nanoparticles.

  2018cites this paper
• Engineering Virus-like Particles for Antigen and Drug Delivery.

  2017cites this paper
• Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing.

  2017cites this paper
• Fluorescent Functionalization across Quaternary Structure in a Virus-like Particle.

  2017cites this paper
• Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery

  2017cites this paper
• Virus-like nanoparticles: emerging tools for targeted cancer diagnostics and therapeutics.

  2017cites this paper
• Engineering Recombinant Virus-like Nanoparticles from Plants for Cellular Delivery.

  2017cites this paper
• Biologically Triggered Delivery of EGF from Polymer Fiber Patches.

  2017cites this paper
• Application of Engineered Viral Nanoparticles in Materials and Medicine

  2017cites this paper
• Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System.

  2016cites this paper
• Viral chemistry: the chemical functionalization of viral architectures to create new technology.

  2016cites this paper
• Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex

  2016cites this paper
• Bioengineered protein-based nanocage for drug delivery.

  2016cites this paper
• Murine polyomavirus VLPs as a platform for cytotoxic T cell epitope-based influenza vaccine candidates

  2016cites this paper
• Design of virus-based nanomaterials for medicine, biotechnology, and energy.

  2016cites this paper
• Optimization of norovirus virus‐like particle production in Pichia pastoris using a real‐time near‐infrared bioprocess monitor

  2016cites this paper
• Effective Delivery of Antigen-Encapsulin Nanoparticle Fusions to Dendritic Cells Leads to Antigen-Specific Cytotoxic T Cell Activation and Tumor Rejection.

  2016cites this paper
• Integrating Display and Delivery Functionality with a Cell Penetrating Peptide Mimic as a Scaffold for Intracellular Multivalent Multitargeting.

  2016cites this paper
• Functional RNAs: combined assembly and packaging in VLPs

  2016cites this paper
• Encapsulins: microbial nanocompartments with applications in biomedicine, nanobiotechnology and materials science.

  2016cites this paper
• "Graft-to" Protein/Polymer Conjugates Using Polynorbornene Block Copolymers.

  2016cites this paper
• High Aspect Ratio Viral Nanoparticles for Cancer Therapy

  2016cites this paper
• The True Story and Advantages of RNA Phage Capsids as Nanotools

  2016cites this paper
• Protein nanoparticles for therapeutic protein delivery.

  2015cites this paper
• Role of Polymer Architecture on the Activity of Polymer-Protein Conjugates for the Treatment of Accelerated Bone Loss Disorders.

  2015cites this paper
• Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle.

  2015cites this paper
• Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.

  2015cites this paper
• The application of virus-like particles as vaccines and biological vehicles

  2015cites this paper
• Virus-Based Nanoparticles as Versatile Nanomachines.

  2015cites this paper
• Quantum Dots Encapsulated with Canine Parvovirus-Like Particles Improving the Cellular Targeted Labeling

  2015cites this paper
• Intracellular Delivery II

  2014cites this paper
• Surface Modification of Melt Extruded Poly(ε-caprolactone) Nanofibers: Toward a New Scalable Biomaterial Scaffold

  2014cites this paper
• Functionalization of protein-based nanocages for drug delivery applications.

  2014cites this paper
• Encapsulation of Biomolecules in Bacteriophage MS2 Viral Capsids

  2014cites this paper
• Modification to the immunodominant loop of hepatitis B virus core protein to enhance vector properties of virus-like particles

  2014cites this paper
• Multifunctional Protein-Based Nanoparticles for Cancer Theranosis

  2014cites this paper
• Exploitation of viral properties for intracellular delivery‡

  2014cites this paper
• Caged protein nanoparticles for drug delivery.

  2014cites this paper
• Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform.

  2014cites this paper
• Production methods for viral particles

  2014cites this paper
• Recent Advances in Engineering Polyvalent Biological Interactions

  2014cites this paper
• Directed polyvalent display of sulfated ligands on virus nanoparticles elicits heparin-like anticoagulant activity.

  2014cites this paper
• Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging

  2014cites this paper
• Production and applications of engineered viral capsids

  2014cites this paper
• A Target-Specific Oral Formulation of Doxorubicin-Protein Nanoparticles: Efficacy and Safety in Hepatocellular Cancer

  2013cites this paper
• Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

  2013cites this paper
• Peptide and protein-based inhibitors of HIV-1 co-receptors

  2013cites this paper
• In vivo virus-based macrofluorogenic probes target azide-labeled surface glycans in MCF-7 breast cancer cells.

  2013cites this paper
• MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform.

  2013cites this paper
• Reengineering viruses and virus-like particles through chemical functionalization strategies.

  2013cites this paper
• CPMV-DOX delivers.

  2013cites this paper
• Crafting precise multivalent architectures

  2013cites this paper
• Polyvalent display of RGD motifs on turnip yellow mosaic virus for enhanced stem cell adhesion and spreading.

  2012cites this paper
• Tools from viruses: bacteriophage successes and beyond.

  2012cites this paper
• Photodynamic activity of viral nanoparticles conjugated with C60.

  2012cites this paper